BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 202937)

  • 1. [Therapies of myasthenia gravis (author's transl)].
    de Crousaz G
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of myasthenia gravis].
    Jerusalem F
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current therapeutic aspects of myasthenia gravis].
    Avilés Mejias S; Ledro Molina D; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(2):139-44. PubMed ID: 6276943
    [No Abstract]   [Full Text] [Related]  

  • 4. [Myasthenia gravis. Recent findings and their therapeutic consequences].
    Thümler R; Haferkamp G
    Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive therapy of myasthenia gravis].
    Lechner H; Ott E; Aranibar A
    Nervenarzt; 1976 Jun; 47(6):353-6. PubMed ID: 183158
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of myasthenia gravis].
    Matell G; von Reis G
    Lakartidningen; 1973 Oct; 70(43):3821-5. PubMed ID: 4362569
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological and therapeutic aspects of myasthenia gravis (author's transl)].
    Ghezzi M; Taiuti R; Marconi G
    Riv Patol Nerv Ment; 1981; 102(1):12-28. PubMed ID: 6285444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of myasthenia gravis--the clinical course and description of intractable cases].
    Mozai T
    Nihon Rinsho; 1971 Nov; 29(11):2525-32. PubMed ID: 4334788
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis (second of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(4):186-93. PubMed ID: 339085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of myasthenia].
    Goulon M; Estournet B; Gajdos P
    Rev Prat; 1979 Jun; 29(35):2789-99. PubMed ID: 493836
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of patients with myasthenia gravis.
    Sanders DB; Scoppetta C
    Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive treatment in neurological disorders].
    Aarli JA
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thymus and myasthenia].
    de Crousaz G; Zoupanos G
    Rev Med Suisse Romande; 1973 Feb; 93(2):143-58. PubMed ID: 4704793
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of myasthenia gravis.
    Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of myasthenia gravis.
    Drug Ther Bull; 1977 Apr; 15(8):29-32. PubMed ID: 872734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of myasthenia gravis].
    Gajdos P
    Presse Med; 1989 Oct; 18(35):1732-4. PubMed ID: 2531386
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing patients who have myasthenia gravis.
    Johns TR
    West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633
    [No Abstract]   [Full Text] [Related]  

  • 20. [Myasthenia gravis].
    Gajdos P
    Rev Prat; 2002 Jan; 52(1):71-7. PubMed ID: 11852770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.